Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger MYM-type 4 pseudogene" (ENSG00000264930) is a **pseudogene** annotated in the Ensembl database. Pseudogenes, by definition, are *genomic DNA sequences similar to normal genes but nonfunctional*; they generally do not encode proteins due to mutations or truncations that prevent translation or result in nonfunctional products.\nThe symbol ENSG00000264930 specifically identifies a pseudogene related to "zinc finger MYM-type 4"—also known as **ZMYM4**—but it does not encode a functional ZMYM4 protein. Functional ZMYM4 (Ensembl: ENSG00000146463) is a MYM-type zinc finger protein involved in DNA binding, cytoskeletal organization, and regulation of cell morphology, with links to cellular proliferation and possible roles in disease, but that function and disease involvement do **not** pertain to the pseudogene form[3][1][2].\nAs a pseudogene, ENSG00000264930 is **not considered a therapeutic target**, has no drug interactions or mechanism of action, and has no known biomarker or disease role.\n\n**Key clarification**:\n- There is a functional protein-coding gene called *Zinc finger MYM-type containing 4* (**ZMYM4**, ENSG00000146463) with real protein and possible disease relevance[3][1][2].\n- ENSG00000264930 refers to a **pseudogene**, not a protein-coding gene, and is not a drug target.\n- If a therapeutic target is intended, the appropriate entry should reference the functional ZMYM4 gene, not the pseudogene.\n\n**Summary:** ENSG00000264930 designates a non-functional pseudogene version of ZMYM4 and should not be considered a valid therapeutic target for drug discovery or intervention.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger MYM-type 4 pseudogene.